Acute Myeloid Leukemia Clinical Trials

A listing of Acute Myeloid Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

patients with relapsed/refractory Acute Myeloid Leukemia (AML) and patients 65 years with initial diagnosis of AML. Primary objectives are: maximum tolerated dose (MTD) and dose

remission
tacrolimus
azacitidine
refractory acute myeloid leukemia (aml)
induction chemotherapy
  • 0 views
  • 12 Jun, 2021
  • 1 location
Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

A Randomized, Double-blind, Multiple-Dose, Two-Cycle, Parallel-Group, Bioequivalence pretrial of Daunorubicin Cytarabine liposome for Injection in older, naive patients with Acute Myeloid

daunorubicin
cytarabine
ejection fraction
  • 0 views
  • 16 Jun, 2021
  • 1 location
Liposomal Cytarabine Daunorubicin and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia

This phase I trial studies the best dose and side effects of liposomal cytarabine, daunorubicin, and gemtuzumab ozogamicin in treating pediatric patients with acute myeloid leukemia that has

  • 0 views
  • 13 Jun, 2021
  • 1 location
Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia

This is a prospective,open-label, single center and single arm phase 1/2 study to evaluate the efficacy and safety of T cells expressing humanized CD7 chimeric antigen receptors treatment for patients with refractory/relapsed CD7 positive acute leukemia.

flow cytometry
acute leukemia
ejection fraction
  • 0 views
  • 11 Jun, 2021
  • 1 location
BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

To assess the efficacy, and safety of BST-236 in patients unfit for intensive chemotherapy with AML or HR MDS that failed or relapsed following first line therapy

acute leukemia
cytarabine
leukemia
carbon monoxide
ejection fraction
  • 0 views
  • 16 Jun, 2021
  • 15 locations
Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

Purpose: The purpose of this trial is to investigate whether a digital array assay can detect trace amounts of residual leukemia and predict relapse in acute myeloid leukemia (AML) patients in

cancer
cell transplantation
remission
  • 0 views
  • 19 Jun, 2021
  • 1 location
Validation Study of a New Cytokine-based Dynamic Stratification Based on FLt3 Ligand Plasma Concentration Kinetic Profile and IL-6 Concentration During Induction of Acute Myeloid Leukemia

The investigators have recently demonstrated the strong impact in terms of survivals of Fms-like tyrosine kinase 3 ligand (FL) levels evaluated during intensive induction in acute myeloid

tyrosine
idarubicin
daunorubicin
leukapheresis
colony stimulating factor
  • 0 views
  • 15 Jun, 2021
  • 25 locations
Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphoma

received by both acute myeloblastic leukemia and lymphoma patients. The tolerance and safety of the vaccination strategy will also be assessed in this specific hematological population.

acute leukemia
leukemia
lymphoma
acute myeloblastic leukemia
vaccination
  • 0 views
  • 16 Jun, 2021
  • 4 locations